Detalhe da pesquisa
1.
Carfilzomib, lenalidomide, and dexamethasone or lenalidomide alone as maintenance therapy after autologous stem-cell transplantation in patients with multiple myeloma (ATLAS): interim analysis of a randomised, open-label, phase 3 trial.
Lancet Oncol
; 24(2): 139-150, 2023 02.
Artigo
Inglês
| MEDLINE | ID: mdl-36642080
2.
Elotuzumab Therapy for Relapsed or Refractory Multiple Myeloma.
N Engl J Med
; 373(7): 621-31, 2015 Aug 13.
Artigo
Inglês
| MEDLINE | ID: mdl-26035255
3.
Elotuzumab plus lenalidomide/dexamethasone for relapsed or refractory multiple myeloma: ELOQUENT-2 follow-up and post-hoc analyses on progression-free survival and tumour growth.
Br J Haematol
; 178(6): 896-905, 2017 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-28677826
4.
Additional genetic abnormalities significantly worsen poor prognosis associated with 1q21 amplification in multiple myeloma patients.
Hematol Oncol
; 31(1): 41-8, 2013 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-22674819
5.
A Stepwise Screening Protocol for Multiple Myeloma.
J Clin Med
; 12(4)2023 Feb 08.
Artigo
Inglês
| MEDLINE | ID: mdl-36835883
6.
Differential Function of a Novel Population of the CD19+CD24hiCD38hi Bregs in Psoriasis and Multiple Myeloma.
Cells
; 10(2)2021 02 16.
Artigo
Inglês
| MEDLINE | ID: mdl-33669402
7.
Elotuzumab, lenalidomide, and dexamethasone in RRMM: final overall survival results from the phase 3 randomized ELOQUENT-2 study.
Blood Cancer J
; 10(9): 91, 2020 09 04.
Artigo
Inglês
| MEDLINE | ID: mdl-32887873
8.
Efficacy of daratumumab monotherapy in real-world heavily pretreated patients with relapsed or refractory multiple myeloma.
Adv Med Sci
; 64(2): 349-355, 2019 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-31125864
9.
Matrix metalloproteinases-1 and -2, and tissue inhibitor of metalloproteinase-2 production is abnormal in bone marrow stromal cells of multiple myeloma patients.
Leuk Res
; 32(11): 1763-9, 2008 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-18472160
10.
Reallife experience with bortezomibbased regimens in elderly patients with newly diagnosed multiple myeloma and comorbidities: a Polish retrospective multicenter study.
Pol Arch Intern Med
; 127(11): 765-774, 2017 11 30.
Artigo
Inglês
| MEDLINE | ID: mdl-28906482
11.
Matrix metalloproteinase and cytokine production by bone marrow adherent cells from multiple myeloma patients.
Arch Immunol Ther Exp (Warsz)
; 54(4): 289-96, 2006.
Artigo
Inglês
| MEDLINE | ID: mdl-16868721
12.
[Evaluation of selected parameters of blood coagulation and the fibrinolysis system in patients undergoing total hip replacement]. / Ocena dynamiki wybranych parametrów krzepniecia i fibrynolizy u chorych poddanych zabiegowi wszczepienia cementowej protezy stawu biodrowego.
Przegl Lek
; 59(7): 502-8, 2002.
Artigo
Polonês
| MEDLINE | ID: mdl-12516238
13.
A clinical comparison of the efficacy and safety of biosimilar G-CSF and originator G-CSF in haematopoietic stem cell mobilization.
Pharmacol Rep
; 66(2): 239-42, 2014 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-24911076
14.
Case-adjusted bortezomib-based strategy in routine therapy of relapsed/refractory multiple myeloma shown to be highly effective--a report by Polish Myeloma Study Group.
Leuk Res
; 38(7): 788-94, 2014 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-24862794
15.
Assessment of plasma prothrombotic factors in patients with Buerger's disease.
Blood Coagul Fibrinolysis
; 24(2): 133-9, 2013 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-23358197
16.
Treatment of multiple myeloma patients with autologous stem cell transplantation - a fresh analysis.
Folia Histochem Cytobiol
; 49(2): 248-54, 2011.
Artigo
Inglês
| MEDLINE | ID: mdl-21744324
17.
JAK2 mutation status, hemostatic risk factors and thrombophilic factors in essential thrombocythemia (ET) patients.
Folia Histochem Cytobiol
; 49(2): 267-71, 2011.
Artigo
Inglês
| MEDLINE | ID: mdl-21744327
18.
Dysregulation of the receptor activator of NF-kappaB ligand and osteoprotegerin production influence the apoptosis of multiple myeloma patients' bone marrow stromal cells co-cultured with myeloma cells.
Arch Immunol Ther Exp (Warsz)
; 58(2): 153-63, 2010 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-20157786
19.
Kynurenic acid in blood and bone marrow plasma of monoclonal gammopathy of undetermined significance (MGUS) and multiple myeloma (MM) patients.
Leuk Res
; 34(1): 38-45, 2010 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-19596432
20.
The efficacy and safety of the low-thalidomide dose CTD (cyclophosphamide, thalidomide, dexamethasone) regimen in patients with multiple myeloma--a report by the Polish Myeloma Study Group.
Leuk Res
; 34(10): 1330-5, 2010 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-20627385